Skip to search formSkip to main contentSkip to account menu

enoximone sulfoxide

Known as: 2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylsulfinyl)benzoyl)-, (2S-(1(R*(R*)),2R*))- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
Enoximone is an imidazole derivative which proved to be a selective inhibitor of the isoenzymes III/IV of the cAMP-specific… 
Review
1991
Review
1991
Enoximone belongs to the imidazole class of compounds, that possess positive inotropic and vasodilatory activities. These… 
1991
1991
Enoximone is a phosphodiesterase inhibitor, which has been studied extensively for use in the management of patients with… 
1990
1990
Cardiac and peripheral vascular effects of enoximone were investigated in a placebo-controlled, crossover, double-blind trial in… 
1988
1988
Experimental factors and determinants of the protein binding of enoximone (a new cardiotonic agent) were investigated in human… 
1987
1987
The pharmacokinetics of enoximone and its sulfoxide metabolite were determined following administration of a single oral dose of…